First In-Human Results of Computed Tomography Angiography for Coronary Stent Assessment With a Spectral Photon Counting Computed Tomography.
Journal
Investigative radiology
ISSN: 1536-0210
Titre abrégé: Invest Radiol
Pays: United States
ID NLM: 0045377
Informations de publication
Date de publication:
01 04 2022
01 04 2022
Historique:
pubmed:
30
10
2021
medline:
26
4
2022
entrez:
29
10
2021
Statut:
ppublish
Résumé
The aim of this study is to compare the image quality of in vivo coronary stents between an energy integrating detectors dual-layer computed tomography (EID-DLCT) and a clinical prototype of spectral photon counting computed tomography (SPCCT). In January to June 2021, consecutive patients with coronary stents were prospectively enrolled to undergo a coronary computed tomography (CT) with an EID-DLCT (IQon, Philips) and an SPCCT (Philips). The study was approved by the local ethical committee and patients signed an informed consent. A retrospectively electrocardiogram-gated acquisition was performed with optimized matching parameters on the 2 scanners (EID-DLCT: collimation, 64 × 0.625 mm; kVp, 120, automatic exposure control with target current at 255 mAs; rotation time, 0.27 seconds; SPCCT: collimation, 64 × 0.275 mm; kVp, 120; mAs, 255; rotation time, 0.33 seconds). The injection protocol was the same on both scanners: 65 to 75 mL of Iomeron (Bracco) at 5 mL/s. Images were reconstructed with slice thickness of 0.67 mm, 512 matrix, XCB (Xres cardiac standard) and XCD (Xres cardiac detailed) kernel, iDose 3 for EID-DLCT and 0.25-mm slice thickness, 1024 matrix, Detailed 2 and Sharp kernel, and iDose 6 for SPCCT. Two experienced observers measured the proximal and distal external and internal diameters of the stents to quantify blooming artifacts. Regions of interest were drawn in the lumen of the stent and of the upstream coronary artery. The difference (Δ S-C) between the respective attenuation values was calculated as a quantification of stent-induced artifacts on intrastent image quality. For subjective image quality, 3 experienced observers graded with a 4-point scale the image quality of different parameters: coronary wall before the stent, stent lumen, stent structure, calcifications surrounding the stent, and beam-hardening artifacts. Eight patients (age, 68 years [interquartile range, 8]; all men; body mass index, 26.2 kg/m2 [interquartile range, 4.2]) with 16 stents were scanned. Five stents were not evaluable owing to motion artifacts on the SPCCT. Of the remaining, all were drug eluting stents, of which 6 were platinum-chromium, 3 were cobalt-platinum-iridium, and 1 was stainless steel. For 1 stent, no information could be retrieved. Radiation dose was lower with the SPCCT (fixed CT dose index of 25.7 mGy for SPCCT vs median CT dose index of 35.7 [IQ = 13.6] mGy; P = 0.02). For 1 stent, the internal diameter was not assessable on EID-DLCT. External diameters were smaller and internal diameters were larger with SPCCT (all P < 0.05). Consequently, blooming artifacts were reduced on SPCCT (P < 0.05). Whereas Hounsfield unit values within the coronary arteries on the 2 scanners were similar, the Δ S-C was lower for SPCCT-Sharp as compared with EID-DLCT-XCD and SPCCT-Detailed 2 (P < 0.05). The SPCCT received higher subjective scores than EID-DLCT for stent lumen, stent structure, surrounding calcifications and beam-hardening for both Detailed 2 and Sharp (all P ≤ 0.05). The SPCCT-Sharp was judged better for stent structure and beam-hardening assessment as compared with SPCCT-Detailed 2. Spectral photon counting CT demonstrated improved objective and subjective image quality as compared with EID-DLCT for the evaluation of coronary stents even with a reduced radiation dose.
Identifiants
pubmed: 34711766
doi: 10.1097/RLI.0000000000000835
pii: 00004424-202204000-00002
pmc: PMC8903215
doi:
Substances chimiques
Platinum
49DFR088MY
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
212-221Informations de copyright
Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
Conflicts of interest and sources of funding: European Union Horizon 2020 research and innovation program under grant agreement no. 668142.
Références
Knuuti J, Wijns W, Saraste A, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J . 2020;41:407–477. doi:10.1093/eurheartj/ehz425.
doi: 10.1093/eurheartj/ehz425
Collet JP, Thiele H, Barbato E, et al. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J . 2021;42:1289–1367. doi:10.1093/eurheartj/ehaa575.
doi: 10.1093/eurheartj/ehaa575
Mahnken AH. CT imaging of coronary stents: past, present, and future. ISRN Cardiol . 2012;2012:139823. doi:10.5402/2012/139823.
doi: 10.5402/2012/139823
Dai T, Wang JR, Hu PF. Diagnostic performance of computed tomography angiography in the detection of coronary artery in-stent restenosis: evidence from an updated meta-analysis. Eur Radiol . 2018;28:1373–1382. doi:10.1007/s00330-017-5097-0.
doi: 10.1007/s00330-017-5097-0
de Graaf FR, Schuijf JD, van Velzen JE, et al. Diagnostic accuracy of 320-row multidetector computed tomography coronary angiography to noninvasively assess in-stent restenosis. Invest Radiol . 2010;45:331–340. doi:10.1097/RLI.0b013e3181dfa312.
doi: 10.1097/RLI.0b013e3181dfa312
Shlofmitz E, Iantorno M, Waksman R. Restenosis of drug-eluting stents. Circ Cardiovasc Interv . 2019;12:1–8. doi:10.1161/CIRCINTERVENTIONS.118.007023.
doi: 10.1161/CIRCINTERVENTIONS.118.007023
Piccolo R, Stefanini GG, Franzone A, et al. Safety and efficacy of resolute zotarolimus-eluting stents compared with everolimus-eluting stents: a meta-analysis. Circ Cardiovasc Interv . 2015;8:e002223. doi:10.1161/CIRCINTERVENTIONS.114.002223.
doi: 10.1161/CIRCINTERVENTIONS.114.002223
Taguchi K, Blevis I, Iniewski K. Spectral, Photon Counting Computed Tomography . Boca Raton, FL: CRC Press; 2021.
Si-Mohamed S, Bar-Ness D, Sigovan M, et al. Review of an initial experience with an experimental spectral photon-counting computed tomography system. Nucl Instrum Methods Phys Res Sect A Accel Spectrometers Detect Assoc Equip . 2017;873:27–35. doi:10.1016/j.nima.2017.04.014.
doi: 10.1016/j.nima.2017.04.014
Si-Mohamed S, Boccalini S, Rodesch PA, et al. Feasibility of lung imaging with a large field-of-view spectral photon-counting CT system. Diagn Interv Imaging . 2021;102:305–312. doi:10.1016/j.diii.2021.01.001.
doi: 10.1016/j.diii.2021.01.001
Boccalini S, Si-Mohamed S, Dessouky R, et al. Feasibility of human vascular imaging of the neck with a large field-of-view spectral photon-counting CT system. Diagn Interv Imaging . 2021;102:329–332. doi:10.1016/j.diii.2020.12.004.
doi: 10.1016/j.diii.2020.12.004
Symons R, Pourmorteza A, Sandfort V, et al. Feasibility of dose-reduced chest CT with photon-counting detectors: initial results in humans. Radiology . 2017;285:980–989. doi:10.1148/radiol.2017162587.
doi: 10.1148/radiol.2017162587
Sarno G, Lagerqvist B, Fröbert O, et al. Lower risk of stent thrombosis and restenosis with unrestricted use of ‘new-generation’ drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Eur Heart J . 2012;33:606–613. doi:10.1093/eurheartj/ehr479.
doi: 10.1093/eurheartj/ehr479
Si-Mohamed SA, Sigovan M, Hsu JC, et al. In vivo molecular K-edge imaging of atherosclerotic plaque using photon-counting CT. Radiology . 2021;300:98–107. doi:10.1148/radiol.2021203968.
doi: 10.1148/radiol.2021203968
Symons R, De Bruecker Y, Roosen J, et al. Quarter-millimeter spectral coronary stent imaging with photon-counting CT: initial experience. J Cardiovasc Comput Tomogr . 2018;12:509–515. doi:10.1016/j.jcct.2018.10.008.
doi: 10.1016/j.jcct.2018.10.008
Sigovan M, Si-Mohamed S, Bar-Ness D, et al. Feasibility of improving vascular imaging in the presence of metallic stents using spectral photon counting CT and K-edge imaging. Sci Rep . 2019;9:19850. doi:10.1038/s41598-019-56427-6.
doi: 10.1038/s41598-019-56427-6
Bratke G, Hickethier T, Bar-Ness D, et al. Spectral photon-counting computed tomography for coronary stent imaging: evaluation of the potential clinical impact for the delineation of in-stent restenosis. Invest Radiol . 2020;55:61–67. doi:10.1097/RLI.0000000000000610.
doi: 10.1097/RLI.0000000000000610
Mannil M, Hickethier T, Von Spiczak J, et al. Photon-counting CT: high-resolution imaging of coronary stents. Invest Radiol . 2018;53:143–149. doi:10.1097/RLI.0000000000000420.
doi: 10.1097/RLI.0000000000000420
Petritsch B, Petri N, Weng AM, et al. Photon-counting computed tomography for coronary stent imaging: in vitro evaluation of 28 coronary stents. Invest Radiol . 2021;56:653–660. doi:10.1097/rli.0000000000000787.
doi: 10.1097/rli.0000000000000787
Steadman R, Herrmann C, Livne A. Nuclear instruments and methods in physics research a ChromAIX2: a large area, high count-rate energy-resolving photon counting ASIC for a spectral CT prototype. Nucl Inst Methods Phys Res A . 2017;862:18–24. doi:10.1016/j.nima.2017.05.010.
doi: 10.1016/j.nima.2017.05.010
Boccalini S, den Harder AM, Witsenburg M, et al. Computed tomography image quality of aortic stents in patients with aortic coarctation: a multicentre evaluation. Eur Radiol Exp . 2018;2:17. doi:10.1186/s41747-018-0046-5.
doi: 10.1186/s41747-018-0046-5
Stefanini GG, Holmes DR Jr. Drug-eluting coronary-artery stents. N Engl J Med . 2013;368:254–265. doi:10.1056/NEJMra1210816.
doi: 10.1056/NEJMra1210816
Maron DJ, Hochman JS, Reynolds HR, et al. Initial invasive or conservative strategy for stable coronary disease. N Engl J Med . 2020;382:1395–1407. doi:10.1056/NEJMoa1915922.
doi: 10.1056/NEJMoa1915922
Mehran R, Mintz GS, Hong MK, et al. Validation of the in vivo intravascular ultrasound measurement of in-stent neointimal hyperplasia volumes. J Am Coll Cardiol . 1998;32:794–799. doi:10.1016/S0735-1097(98)00316-7.
doi: 10.1016/S0735-1097(98)00316-7
Waksman R, Kitabata H, Prati F, et al. Intravascular ultrasound versus optical coherence tomography guidance. J Am Coll Cardiol . 2013;62(suppl 17):S32–S40. doi:10.1016/j.jacc.2013.08.709.
doi: 10.1016/j.jacc.2013.08.709
Pugliese F, Cademartiri F, van Mieghem C, et al. Multidetector CT for visualization of coronary stents. Radiographics . 2006;26:887–904. doi:10.1148/rg.263055182.
doi: 10.1148/rg.263055182
Si-mohamed SA, Greffier J, Miailhes J, et al. Comparison of image quality between spectral photon-counting CT and dual-layer CT for the evaluation of lung nodules: a phantom study [published online ahead of print June 29, 2021]. Eur Radiol .
van der Werf NR, Si-Mohamed S, Rodesch PA, et al. Coronary calcium scoring potential of large field-of-view spectral photon-counting CT: a phantom study [published online ahead of print July 13, 2021]. Eur Radiol .
Tan S, Soulez G, Diez Martinez P, et al. Coronary stent artifact reduction with an edge-enhancing reconstruction kernel—a prospective cross-sectional study with 256-slice CT. PLoS One . 2016;11:e0154292. doi:10.1371/journal.pone.0154292.
doi: 10.1371/journal.pone.0154292
Von Spiczak J, Mannil M, Peters B, et al. Photon counting computed tomography with dedicated sharp convolution kernels: tapping the potential of a new technology for stent imaging. Invest Radiol . 2018;53:486–494. doi:10.1097/RLI.0000000000000485.
doi: 10.1097/RLI.0000000000000485
Barrett JF, Keat N. Artifacts in CT: recognition and avoidance. Radiographics . 2004;24:1679–1691. doi:10.1148/rg.246045065.
doi: 10.1148/rg.246045065
Lin E, Alessio A. What are the basic concepts of temporal, contrast, and spatial resolution in cardiac CT? J Cardiovasc Comput Tomogr . 2009;3:403–408. doi:10.1016/j.jcct.2009.07.003.
doi: 10.1016/j.jcct.2009.07.003
Litmanovich DE, Tack DM, Shahrzad M, et al. Dose reduction in cardiothoracic CT: review of currently available methods. Radiographics . 2014;34:1469–1489. doi:10.1148/rg.346140084.
doi: 10.1148/rg.346140084